| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.246 | 31.019 | 26.979 | 25.811 | 22.557 | 27.978 | 26.377 | 38.297 | 43.760 | 42.177 |
| Total Income - EUR | 29.269 | 31.036 | 28.293 | 25.926 | 22.557 | 27.978 | 26.393 | 38.379 | 43.760 | 42.713 |
| Total Expenses - EUR | 33.535 | 32.106 | 30.999 | 30.696 | 25.794 | 27.066 | 27.674 | 37.752 | 42.953 | 42.185 |
| Gross Profit/Loss - EUR | -4.266 | -1.070 | -2.707 | -4.770 | -3.237 | 912 | -1.281 | 627 | 807 | 528 |
| Net Profit/Loss - EUR | -5.145 | -1.380 | -2.990 | -5.029 | -3.463 | 650 | -1.540 | 304 | 378 | 109 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Farmacia Belladona S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.615 | 14.348 | 13.989 | 13.619 | 13.244 | 12.884 | 12.491 | 12.458 | 12.420 | 12.351 |
| Current Assets | 6.665 | 5.442 | 3.481 | 4.947 | 3.180 | 3.985 | 2.971 | 5.035 | 6.429 | 5.655 |
| Inventories | 1.436 | 715 | 1.472 | 1.781 | 1.066 | 1.940 | 1.204 | 710 | 1.271 | 1.939 |
| Receivables | 1.548 | 2.153 | 1.506 | 1.478 | 0 | 0 | 0 | 0 | 694 | 726 |
| Cash | 3.681 | 2.575 | 503 | 1.688 | 2.113 | 2.045 | 1.766 | 4.325 | 4.464 | 2.991 |
| Shareholders Funds | 19.276 | 17.700 | 14.410 | 9.117 | 5.478 | 6.023 | 4.350 | 4.668 | 7.560 | 7.606 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.004 | 2.090 | 3.060 | 9.449 | 10.946 | 10.846 | 11.111 | 12.824 | 11.289 | 10.399 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Belladona S.r.l.